Daniel Wolle

Stock Analyst

(n/a)

# 4,648

Out of 4,648 analysts

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Stocks Rated by Daniel Wolle

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ITOS iTeos Therapeutics	Maintains: Overweight	$32 → $29	$8.97	+223.30%	2	Nov 13, 2023
	CARA Cara Therapeutics	Maintains: Overweight	$19 → $16	$0.29	+5,383.21%	1	Mar 7, 2023

iTeos Therapeutics

Nov 13, 2023

Maintains: Overweight

Price Target: $32 → $29

Current: $8.97

Upside: +223.30%

Cara Therapeutics

Mar 7, 2023

Maintains: Overweight

Price Target: $19 → $16

Current: $0.29

Upside: +5,383.21%